"At Unison Clinical Trials, we are committed to assessing the safety and effectiveness of the latest drugs, medications and treatments that promise optimal health outcomes for individuals who are diagnosed with chronic diseases. In this way, we provide our Los Angeles patients with progressive care that may deliver profound and lasting relief from their conditions."

During the past decade, UNISON Clinical Trials conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNISON Clinical Trials" #1 sponsor was "Amgen" with 2 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Aleor Dermaceuticals Limited" with 1 trials sponsored and "Aurigene Discovery Technologies Limited" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNISON Clinical Trials" #1 collaborator was "Allergan Sales, LLC" with 1 trials as a collaborator, "Catawba Research" with 1 trials as a collaborator and "Catawba Research, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UNISON Clinical Trials" are "Plaque Psoriasis" (5 trials), "Acne Vulgaris" (2 trials), "Colorectal Cancer" (2 trials), "Psoriasis" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "UNISON Clinical Trials" in a lesser frequency.

Most popular intervention types in "UNISON Clinical Trials" are "Drug" (10 trials), "Other" (4 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "BMS-986165" (2 trials), "Guselkumab" (2 trials), "ABP 501" (1 trials) and "ABP 654" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNISON Clinical Trials" are 13 trials for "All" genders.

Currently, there are NaN active trials in "UNISON Clinical Trials". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in UNISON Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNISON Clinical Trials, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".